Drug Trial Radar · NCT01929434
Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis
Last checked: Nov 20, 2026Latest source record: Dec 27, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Oct 2013
Primary completion
Dec 2015
Study completion Dec 2016
Sponsor
- Lead sponsor
- General Hospital of Chinese Armed Police ForcesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 28, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Cerebral palsy (CP) is described as a group of permanent disorders affecting motor development and posture, resulting in activity limitation attributed to nonprogressive disturbances of the fetal or infant brain. The prevalence of cerebral palsy has increased among the children with low birth-weight, jaundice, respiratory distress and intrauterine infection and so on. The incidence of cerebral palsy is increasing gradually with increased neonatal survival rate. Although there are many kinds of functional therapy programs especially the rehabilitation treatment for cerebral palsy, their effects are limited. Increasing cerebral palsy patients become a heavy burden to the family and society. Stem cell based therapy, a new prospective therapy for central nervous system disorders, has the potential to repair the damaged brain tissue in patients with cerebral palsy. In this study, 300 patients with cerebral palsy will be divided into three groups and the investigators will use mesenchymal stem cells derived from umbilical cord to treat 100 CP patients of them randomly. We will also follow up the other 100 patients who only receive rehabilitation treatment and another 100 patients who accept neither stem cell therapy nor rehabilitation treatment. On this basis, as the investigators we can compare the efficacy of cell therapy and rehabilitation treatments for cerebral palsy patients. Multiple sources of assessment were used to ascertain and classify all cases of cerebral palsy. Particularly the Gross Motor Function Measure (GMFM) as an important valid and reliable outcome measure, has made it possible to evaluate the severity of movement disability,change over time and the effects of clinical interventions. It also will be the primary outcome measure in follow-up analysis of this study.
Conditions
- Cerebral Palsy
Interventions
rehabilitationOther
Patients only receive rehabilitation of physical therapy and occupational therapy.
stem cell injectionBiological
Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Gross Motor Function Measure ScoreTime frame: Change from baseline at 12 monthes after enrollment or transplantation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
General Hospital of Chinese People's Armed Police Forces
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.